TipRanks
Maze Therapeutics, Inc. (MAZE)
NASDAQ:MAZE
US Market
Want to see MAZE full AI Analyst Report?

Maze Therapeutics, Inc. (MAZE) Ownership - Who Owns Maze Therapeutics, Inc.?

125 Followers

Maze Therapeutics, Inc. (MAZE) Ownership Overview

10.93%5.50%<0.01%9.52%74.04%
10.93% Insiders
<0.01% Other Institutional Investors
9.52% ETFs
74.04% Public Companies and
Individual Investors
The ownership structure of Maze Therapeutics, Inc. (MAZE) stock is a mix of institutional, retail, and individual investors. Approximately 15.03% of the company’s stock is owned by Institutional Investors, 10.93% is owned by Insiders, and 74.04% is owned by Public Companies and Individual Investors.
The ownership structure of Maze Therapeutics, Inc. (MAZE) stock is a mix of institutional, retail, and individual investors. Approximately 5.51% of the company’s stock is owned by Institutional Investors, 10.93% is owned by Insiders, and 9.52% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 04, 2026
xxxxxxxxxxxxx
$104748
Sep 04, 2026
xxxxxxxxxxxxx
$593856
Sep 04, 2026
xxxxxxxxxxxxx
$168783
Sep 04, 2026
xxxxxxxxxxxxx
$270066

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,424,758Insider9.77%171,910,581
2,147,550Institution3.87%68,055,860
1,877,431Institution3.38%59,495,788
1,397,151Institution2.52%44,275,715
1,107,814Institution1.99%35,106,626
954,886Institution1.72%30,260,337
736,216Institution1.33%23,330,685
480,000Institution0.86%15,211,200
464,903Institution0.84%14,732,776
328,700Insider0.59%10,416,503

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,397,151Institution2.52%44,275,715
311,885Institution0.56%9,883,636
296,688Institution0.53%9,402,043
226,736Institution0.41%7,185,264
184,453Institution0.33%5,845,316
140,394Institution0.25%4,449,086
124,269Institution0.22%3,938,085
72,391Institution0.13%2,294,071
57,021Institution0.10%1,806,995
47,209Institution0.08%1,496,053

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,411,990Institution2.54%38,377,888
887,072Institution1.60%28,111,312
418,401Institution0.75%11,372,139
327,779Institution0.59%10,184,094
278,193Institution0.50%8,815,936
263,255Institution0.47%8,342,551
205,216Institution0.37%5,577,771
195,449Institution0.35%6,072,600
125,869Institution0.23%3,988,789
123,693Institution0.22%3,919,831

FAQ

Who Owns Maze Therapeutics, Inc. (MAZE)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 10.93% is held by insiders, and 74.04% is held by retail investors.
    What percentage of Maze Therapeutics, Inc. (MAZE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Maze Therapeutics, Inc. (MAZE) stock is held by institutional investors.
      What percentage of Maze Therapeutics, Inc. (MAZE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 74.04% of Maze Therapeutics, Inc. (MAZE) stock is held by retail investors.
        Who owns the most shares of Maze Therapeutics, Inc. (MAZE)?
        Third Rock Ventures IV, L.P. owns the most shares of Maze Therapeutics, Inc. (MAZE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.